Overview

Effect of Linagliptin in Comparison With Glimepiride as Add on to Metformin on Postprandial Beta Cell Function, Postprandial Metabolism and Oxidative Stress in Patients With Type 2 Diabetes Mellitus

Status:
Unknown status

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

The goal of this mechanistic study is to investigate the effect of Linagliptin in comparison to Glimepiride as add on therapy on several parameters characterizing postprandial metabolism and oxidative stress in type 2 diabetic patients on stable control with metformin.

Phase:

Phase 4

Details

Lead Sponsor:

Marcus Borchert

Collaborators:

Boehringer Ingelheim
ikfe-CRO GmbH

Treatments:

Glimepiride
Linagliptin
Metformin